Newsroom

Portrait Caroline Klett-Tammen
Interview
Poliomyelitis, also known as polio, is a contagious disease caused by the poliovirus. Thanks to the development of effective vaccines, the poliovirus has been largely eradicated and was endemic in only two countries in 2024. However, until the virus is eradicated worldwide, vaccination protection is important in Germany as well, as the virus could be reintroduced at any time. Epidemiologists at the Helmholtz Centre for Infection Research (HZI) have now shown that many people do not know their vaccination status and cannot find it on their vaccination record. In an interview on the occasion of World Polio Day on October 24, Dr. Carolina Klett-Tammen, deputy head of Clinical Epidemiology in the department “Epidemiology” at the HZI, explains the study results, which have been published in the journal BMC Public Health.
23.10.2025
Light microscopy of red blood cells, some are infected with Plasmodium
News
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite. To counteract this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has now developed a new drug candidate that can kill the malaria pathogen even when existing drugs are no longer effective. The team has now published its findings in the journal Angewandte Chemie.
22.10.2025
Fluorescence microscopy of cells in magenta and blue
News
Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in very small quantities. A research team from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) led by Tobias Gulder has now succeeded in establishing a chemo-enzymatic platform for the production of furanolides – a class of natural products with a broad spectrum of activity. This strategy not only allows furanolides to be produced cost-effectively, but also enables structural modifications to be made. The newly generated molecules are capable of effectively combating both bacterial pathogens and cancer cells. The team has now published its findings in the Journal of the American Chemical Society.
20.10.2025
Two speakers in front of a presentation on a screen
News
On 9 and 10 October 2025, the One Lab Retreat of the Helmholtz Centre for Infection Research (HZI) took place at the Wyndham Hannover Atrium. Researchers, managers and task force representatives from all HZI sites came together to present current scientific results, discuss interdisciplinary topics and further develop strategic cooperation.
13.10.2025
Rolf Müller
News
Professor Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biology at Saarland University, has been awarded the Mannich Medal by the German Pharmaceutical Society (DPhG). Awarded in honour of the German chemist Carl Mannich, the medal is the DPhG's highest scientific accolade and is presented annually for “outstanding achievements in the field of pharmaceutical sciences”. The medal was presented at the DPhG's annual conference in Freiburg on October 1, 2025. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.
07.10.2025
A woman puts a strip of chewing gum in her mouth
News
Influenza is much more than just a nasty cold – it is one of the most dangerous infectious diseases worldwide, claiming around half a million lives every year. What makes it particularly insidious is that flu viruses are contagious even before the first symptoms appear. Despite this threat, the diagnostic options available to date are far from ideal. They are often expensive, complicated to use and simply unavailable in many poorer regions of the world. A research team led by Professor Lorenz Meinel from the University of Würzburg in cooperation with researchers from the Helmholtz Centre for Infection Research has developed the technology behind a new self-test for influenza, recently published in ACS Central Science.
02.10.2025

HZI in the media

... der MHH, des TWINCORE Hannover und des Helmholtz-Instituts für Infektionsforschung (HZI). Ihre wissenschaftliche Expertise ...

21.01.2026
|
hannover.de

... auch Teil des Ecoversity-Programms der Technischen Universität Braunschweig.

 

GN De hlth| Source | domain www.helmholtz-hzi.

20.01.2026
|
Die heutigen Nachrichten

... validierte Daten der MHH und des Helmholtz-Zentrum für Infektionsforschung (HZI), die zeitnah in Fachjournalen veröffentlichet ...

19.01.2026
|
wallstreet:online

... maßgeblich vorantreiben. In Zusammenarbeit mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung (HZI) und der Utah State ...

16.01.2026
|
IT Boltwise

... Deutschen Zentrum für Neurodegenerative Erkrankungen, am Helmholtz-Zentrum für Infektionsforschung und am Max-Delbrück-Centrum für ...

16.01.2026
|
Handelsblatt

Lange , Kommissarische Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig, gegenüber dem

16.01.2026
|
Medscape

Das interdisziplinäre Team aus TWINCORE , Helmholtz Zentrum für Infektionsforschung (HZI) und der Medizinischen Hochschule Hannover ( ...

15.01.2026
|
Arzt & Wirtschaft

Manche fordern Placebo-kontrollierte Vergleiche von Geimpften und Ungeimpften, um die Sicherheit der Masern-Impfung zu testen. ...

15.01.2026
|
BR Bayerischer Rundfunk

... können wir Pandemien früh erkennen? Forschende des Helmholtz‑Instituts für One Health zeigen, warum Mensch, ...

13.01.2026
|
Deutsche Welle

... gewinnbringend eingesetzt werden. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit ...

13.01.2026
|
juraforum.de

... nach SARS-CoV-2, sagt Fabian Leendertz. Er ist Direktor des Helmholtz-Instituts für One Health (HIOH) in ...

13.01.2026
|
Deutsche Welle

from the University Hospital Würzburg (UKW), the Helmholtz Institute for RNA-based Infection Research (HIRI), and University of Münster. The

12.01.2026
|
MSN.com

Register now for the HZI-Newsletter